Enhanced bioavailability of tamoxifen after oral administration of tamoxifen with quercetin in rats

International Journal of Pharmaceutics
Sang-Chul ShinXiuguo Li

Abstract

Orally administered tamoxifen undergoes a first-pass metabolism and substrates for multidrug resistance (MDR) transporters efflux in the liver and intestines, which obstructs its systemic exposure. This study investigated the effect of quercetin, a dual inhibitor of CYP3A4 and P-gp, on the bioavailability and pharmacokinetics of tamoxifen and one of its metabolites, 4-hydroxytamoxifen, in rats. The pharmacokinetic parameters of tamoxifen and 4-hydroxytamoxifen in plasma were determined after orally administering tamoxifen (10 mg/kg) with or without quercetin (2.5, 7.5 and 15 mg/kg). The coadministration of quercetin (2.5 and 7.5 mg/kg) significantly (p < 0.05) increased the absorption rate constant (K(a)), peak concentration (C(max)) and the areas under the plasma concentration-time curve (AUC) of tamoxifen. The absolute bioavailability (AB%) of tamoxifen with 2.5 and 7.5 mg/kg quercetin ranged from 18.0% to 24.1%, which was significantly higher than the control group, 15.0% (p < 0.05). The relative bioavailability (RB%) of tamoxifen coadministered with quercetin was 1.20-1.61 times higher than the control group. The coadministration of quercetin caused no significant changes in the terminal half-life (t(1/2)) and the time to r...Continue Reading

Citations

Dec 23, 2008·Archives of Pharmacal Research·Jun-Shik Choi, Keon Wook Kang
Feb 28, 2013·Nutrition and Cancer·Fatemeh T ShamsabadiSuhaila Mohamed
Jan 16, 2013·Chemotherapy Research and Practice·Katrin Sak
May 3, 2013·BMC Complementary and Alternative Medicine·Marcos Correa DiasLuís Fernando Barbisan
Apr 30, 2009·BMC Medical Genomics·Joshua C KwekelTimothy R Zacharewski
Nov 22, 2011·Drug Metabolism and Drug Interactions·Tapas Kumar SarTapan Kumar Mandal
Jan 1, 2011·International Journal of Applied & Basic Medical Research·Gurpreet Kaur Randhawa Rajkumar
Feb 7, 2014·Journal of Biosciences·Ishtiyaq Ahmad Najar, Rakesh Kamal Johri
Oct 17, 2014·Cancer Chemotherapy and Pharmacology·Joel M ReidMatthew M Ames
Mar 29, 2013·International Journal of Pharmaceutics·Harshad SheteVandana Patravale
Apr 22, 2015·Seminars in Cancer Biology·Mark A FeitelsonSomaira Nowsheen
Oct 3, 2012·TheScientificWorldJournal·Ghanshyam B DudhatraBhavesh N Chauhan
Oct 11, 2015·The Journal of Pharmacy and Pharmacology·Xinru LiGuiling Li
Jul 20, 2010·Life Sciences·Chen ChenChunyan Ji
Apr 18, 2008·The Journal of Pharmacy and Pharmacology·Yong-Ji Piao, Jun-Shik Choi
Dec 28, 2007·Developmental Dynamics : an Official Publication of the American Association of Anatomists·Eon Joo ParkAnne M Moon
Sep 28, 2010·Journal of Biomedical Materials Research. Part a·M Dolores BlancoJosé M Teijón
Jan 25, 2012·Journal of Drug Delivery·E MonteagudoA M Carlucci
Sep 17, 2013·Pharmaceutical Development and Technology·Fahima M HashemAhmed Khairy
Apr 8, 2014·International Journal of Pharmaceutics·Harshad K SheteVandana B Patravale
Apr 5, 2011·Food and Chemical Toxicology : an International Journal Published for the British Industrial Biological Research Association·Aneliya HaritovaLubomir Lashev
Jan 15, 2014·Journal of Controlled Release : Official Journal of the Controlled Release Society·P L Lam, R Gambari
May 8, 2013·Journal of Controlled Release : Official Journal of the Controlled Release Society·Kaushik ThankiSanyog Jain
Jun 11, 2014·Critical Reviews in Food Science and Nutrition·Hafiz Ansar Rasul SuleriaNauman Khalid
May 18, 2016·The Kaohsiung Journal of Medical Sciences·Liang ZouLian-Xin Peng
Jul 23, 2016·Tumour Biology : the Journal of the International Society for Oncodevelopmental Biology and Medicine·Dharambir KashyapHardeep Singh Tuli
Oct 30, 2016·International Journal of Biological Macromolecules·Chao FengXi Guang Chen
Oct 30, 2007·The American Journal of Chinese Medicine·Xiaohui ZhengJianbin Zheng
Feb 4, 2010·Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology·Kazuma KiyotaniHitoshi Zembutsu

❮ Previous
Next ❯

Related Concepts

Trending Feeds

COVID-19

Coronaviruses encompass a large family of viruses that cause the common cold as well as more serious diseases, such as the ongoing outbreak of coronavirus disease 2019 (COVID-19; formally known as 2019-nCoV). Coronaviruses can spread from animals to humans; symptoms include fever, cough, shortness of breath, and breathing difficulties; in more severe cases, infection can lead to death. This feed covers recent research on COVID-19.

Blastomycosis

Blastomycosis fungal infections spread through inhaling Blastomyces dermatitidis spores. Discover the latest research on blastomycosis fungal infections here.

Nuclear Pore Complex in ALS/FTD

Alterations in nucleocytoplasmic transport, controlled by the nuclear pore complex, may be involved in the pathomechanism underlying multiple neurodegenerative diseases including Amyotrophic Lateral Sclerosis and Frontotemporal Dementia. Here is the latest research on the nuclear pore complex in ALS and FTD.

Applications of Molecular Barcoding

The concept of molecular barcoding is that each original DNA or RNA molecule is attached to a unique sequence barcode. Sequence reads having different barcodes represent different original molecules, while sequence reads having the same barcode are results of PCR duplication from one original molecule. Discover the latest research on molecular barcoding here.

Chronic Fatigue Syndrome

Chronic fatigue syndrome is a disease characterized by unexplained disabling fatigue; the pathology of which is incompletely understood. Discover the latest research on chronic fatigue syndrome here.

Evolution of Pluripotency

Pluripotency refers to the ability of a cell to develop into three primary germ cell layers of the embryo. This feed focuses on the mechanisms that underlie the evolution of pluripotency. Here is the latest research.

Position Effect Variegation

Position Effect Variagation occurs when a gene is inactivated due to its positioning near heterochromatic regions within a chromosome. Discover the latest research on Position Effect Variagation here.

STING Receptor Agonists

Stimulator of IFN genes (STING) are a group of transmembrane proteins that are involved in the induction of type I interferon that is important in the innate immune response. The stimulation of STING has been an active area of research in the treatment of cancer and infectious diseases. Here is the latest research on STING receptor agonists.

Microbicide

Microbicides are products that can be applied to vaginal or rectal mucosal surfaces with the goal of preventing, or at least significantly reducing, the transmission of sexually transmitted infections. Here is the latest research on microbicides.